Clinical Trial Update: BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) [EARLY_Phase 1]

View source ↗

Summary

This clinical trial evaluating onabotulinumtoxinA (BOTOX) for men with prostate cancer and lower urinary tract symptoms/benign prostatic hyperplasia has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Prostate Cancer

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Prostate Cancer, Benign Prostatic Hyperplasia | EARLY_Phase 1 | Status: WITHDRAWN